Cite
HARVARD Citation
Calò, L. et al. (n.d.). Angiotensin-converting enzyme inhibitors, angiotensin II type 1 receptor blockers and risk of COVID 19. Journal of hypertension. 38 (7), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Calò, L. et al. (n.d.). Angiotensin-converting enzyme inhibitors, angiotensin II type 1 receptor blockers and risk of COVID 19. Journal of hypertension. 38 (7), p. . [Online].